Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Immunotherapy for early breast cancer: too soon, too superficial, or just right?Franzoi, M.A. ; Romano, E. ; Piccart, M.Annals of oncology, 2021-03, Vol.32 (3), p.323-336 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept studyCabel, L. ; Riva, F. ; Servois, V. ; Livartowski, A. ; Daniel, C. ; Rampanou, A. ; Lantz, O. ; Romano, E. ; Milder, M. ; Buecher, B. ; Piperno-Neumann, S. ; Bernard, V. ; Baulande, S. ; Bieche, I. ; Pierga, J.Y. ; Proudhon, C. ; Bidard, F.-C.Annals of oncology, 2017-08, Vol.28 (8), p.1996-2001 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Baseline blood immune profiling to predict response to antiPD-1 in patients with advanced non-small cell lung cancerRomano, E. ; Le Bourgeois, T. ; Lopez-Lastra, S. ; Servois, V. ; Beaucaire-Danel, S. ; Daniel, C. ; Pierga, J.-Y. ; Bidard, F.-C. ; Lantz, O.Annals of oncology, 2018-10, Vol.29, p.viii34-viii34 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
30P Protein signature associated with response and progression free survival in late-stage NSCLC patients treated with anti-PD-1 blockadeRomano, E. ; Sklodowski, K. ; Dozio, V. ; Lanzós, A. ; Beeler, K.Annals of oncology, 2021-03, Vol.32, p.S12-S12 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
20P Identifying novel biomarkers with deep proteomics profiling and survival analysis in NSCLC patients treated with anti-PD-1-blockadeNguyen, E. ; Poli, R. ; Sklodowski, K. ; Dozio, V. ; Lanzós, A. ; Beeler, K. ; Romano, E.Annals of oncology, 2021-12, Vol.32, p.S1382 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
1250P A holistic perspective on plasma proteome changes associated with response to anti-PD-1 treatment in NSCLC patientsRomano, E. ; Dozio, V. ; Lopez-Lastra, S. ; Sklodowski, K. ; Beeler, K.Annals of oncology, 2020-09, Vol.31, p.S808-S809 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
98P Neo-CheckRay, radiation therapy and adenosine pathway blockade to potentiate benefit of immuno-chemotherapy in early stage luminal B breast cancer: Results of the safety run-in phaseDe Caluwe, A. ; Romano, E. ; Poortmans, P. ; Gombos, A. ; Laragione, A. ; Agostinetto, E. ; Nader Marta, G. ; Picchia, S. ; Vandekerkhove, C. ; Ameye, L. ; Craciun, L. ; Veys, I. ; Van Gestel, D. ; Larsimont, D. ; Sotiriou, C. ; Piccart, M. ; Ignatiadis, M. ; Buisseret, L.Annals of oncology, 2022-05, Vol.33, p.S170-S170 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
LBA70 COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databasesRomano, E. ; Castelo-Branco, L. ; Tsourti, Z. ; de Azambuja, E. ; Gennatas, S. ; Oliveira, J. ; Rogado, J. ; Sekacheva, M. ; Susnjar, S. ; Lozano, D. Vinal ; Lee, R. ; Khallaf, S.M. ; Dimopoulou, G. ; Pradervand, S. ; Arnold, D. ; Harrington, K.J. ; Michielin, O.A. ; Dafni, U. ; Pentheroudakis, G. ; Peters, S.Annals of oncology, 2022-09, Vol.33, p.S1437-S1437 [Periódico revisado por pares]European Society for Medical Oncology. Published by Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
84TiP Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer: A randomized phase II trialDe Caluwe, A. ; Buisseret, L. ; Poortmans, P. ; Sotiriou, C. ; Larsimont, D. ; Van Gestel, D. ; Laragione, A. ; Desmet, A. ; Van Den Begin, R. ; Philippson, C. ; Eiger, D. ; Piccart, M. ; Romano, E. ; Ignatiadis, M.Annals of oncology, 2020-12, Vol.31, p.S1451-S1451 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
217O Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 studyJoshua, A.M. ; Gurney, H. ; Retz, M. ; Tafreshi, A. ; Fong, P.C.C. ; Shore, N.D. ; Romano, E. ; Augustin, M. ; Piulats, J.M. ; Berry, W.R. ; Kolinsky, M.P. ; Sridhar, S.S. ; Conter, H.J. ; Todenhöfer, T. ; Appleman, L.J. ; Wu, H. ; Schloss, C. ; Poehlein, C.H. ; de Bono, J.S. ; Yu, E.Y.Annals of oncology, 2020-11, Vol.31, p.S1325-S1325 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |